Assessment of the Relationship Between Migraine, Headache and Third Window Syndrome
Main Article Content
Abstract
Migraine is a symptomatically heterogeneous condition, of which headache is just one manifestation. This disorder is associated with altered sensory thresholding, with hypersensitivity among migraine sufferers to different sensory inputs. Hence, we suggest that sensitivity to the gravitational receptor asymmetries seen in third window syndrome is triggering migraine symptoms via this hypersensitivity-associated mechanism. When measuring the impact of headache and migraine headache in the lives of patients with third window syndrome as well as the response to surgical intervention it is essential to incorporate a validated survey instrument into clinical practice. We have found that the six-item Headache Impact Test (HIT-6) in several different cohorts has demonstrated a highly statistically significant symptom improvement after surgical management of patients with third window syndrome. This review provides the background of the spectrum of sites of inner ear dehiscence resulting in third window syndrome, as well as other manifestations of the syndrome in the context of headache and migraine in these patients.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Stenfelt, S., & Goode, R.L. (2005). Bone-conducted sound: physiological and clinical aspects. Otol Neurotol 26:1245–46. doi: 10.1097/01.mao.0000187236.10842.d5
3. Black, F.O., Pesznecker, S., Norton, T., et al. (1992). Surgical management of perilymphatic fistulas: a Portland experience. Am J Otol 13:254–62.
4. Wackym, P.A., Balaban, C.D., Mowery, T.M. (2023). History and overview of third mobile window syndrome. In: G.J. Gianoli, P. Thomson (Eds.), Third Mobile Window Syndrome of the Inner Ear. Springer Nature, Switzerland AG, pp. 3-25.
5. Mowery, T.M., Balaban, C.D., Wackym, P.A. (2023). The cognitive/psychological effects of third mobile window syndrome. In: G.J. Gianoli, P. Thomson (Eds.), Third Mobile Window Syndrome of the Inner Ear. Springer Nature, Switzerland AG, pp. 107-119.
6. Naert, L., Van de Berg, R., Van de Heyning, P., et al. (2018). Aggregating the symptoms of superior semicircular canal dehiscence syndrome. Laryngoscope 128(8):1932-1938. doi: 10.1002/lary.27062
7. Wackym, P.A., Balaban, C.D., Zhang, P., Siker, D.A., Hundal, J.S. Third window syndrome: surgical management of cochlea-facial dehiscence. Front Neurology 2019;10:1281. doi:10.3389/fneur.2019.01281
8. Kohut, R.I. (1992). Perilymph fistulas. Clinical criteria. Arch Otolaryngol Head Neck Surg 118(7):687-92. doi: 10.1001/archotol.1992.01880070017003
9. Wackym, P.A. (2012). Vestibular migraine. Patient video describing symptoms before and after treatment with Topamax. https://www.youtube.com/watch?v=Zy7YjCDnLYM. doi: 10.13140/RG.2.1.3096.2647. Published 12 April 2012. (Accessed 1 January 2025). Copyright © P.A. Wackym, MD, used with permission.
10. Wackym, P.A. (2012). Right perilymph fistula not superior canal dehiscence. Patient video describing symptoms before and after surgical repair. https://www.youtube.com/watch?v=bDph0B0uLbg. doi: 10.13140/RG.2.1.3097.8000. Published 12 November 2012. (Accessed 1 January 2025). Copyright © P.A. Wackym, MD, used with permission.
11. Wackym, P.A. (2019). Right cochlea-facial nerve dehiscence: 16 year old thought to have conversion disorder. https://youtu.be/fTjsnnUALBw. doi: 10.13140/RG.2.2.27418.90564. Published 14 April 2019. (Accessed 1 January 2025). Copyright © P.A. Wackym, MD, used with permission.
12. Wackym, P.A. (2012). Perilymph fistula. https://www.youtube.com/watch?v=jSAM6h-7Mwc. doi: 10.13140/RG.2.1.1000.6488. Published 15 April 2012. (Accessed 1 January 2025). Copyright © P.A. Wackym, MD, used with permission.
13. Wackym, P.A. (2017). Right superior semicircular canal dehiscence repair: Symptoms and recovery. https://youtu.be/er4k8NZrG2I. doi: 10.13140/RG.2.2.32032.79361. Published 9 January 2017. (Accessed 1 January 2025). Copyright © P.A. Wackym, MD, used with permission.
14. Wackym, P.A. (2017). Recurrent third window syndrome co-morbidity: Functional neurological symptom disorder. https://youtu.be/AgUy07QxTxo. doi: 10.13140/RG.2.2.15255.57763. Published 9 January 2017. (Accessed 1 January 2025). Copyright © P.A. Wackym, MD, used with permission.
15. Wackym, P.A. (2015). Otic capsule dehiscence syndrome in one ear after a car accident. https://www.youtube.com/watch?v=1Nl9T6etxqM. doi: 10.13140/RG.2.1.3359.9440. Published 5 April 2015. (Accessed 1 January 2025). Copyright © P.A. Wackym, MD, used with permission.
16. Wackym, P.A. (2019). Cochlea-facial nerve dehiscence: Traumatic third window syndrome after a snowboarding accident. https://youtu.be/NCDMD5FGf-w. doi: 10.13140/RG.2.2.17283.76327. Published 9 April 2019. (Accessed 1 January 2025). Copyright © P.A. Wackym, MD, used with permission.
17. Wackym, P.A. (2019). Surgery for cochlea-facial nerve dehiscence: Symptoms and tuning fork testing. https://youtu.be/lFR-zdYlIsY. doi: 10.13140/RG.2.2.34129.79209. Published 14 April 2019. (Accessed 1 January 2025). Copyright © P.A. Wackym, MD, used with permission.
18. Wackym, P.A. (2015). Tuning fork testing in otic capsule dehiscence syndrome. https://www.youtube.com/watch?v=Szp_kO8oVos. doi: 10.13140/RG.2.1.4408.5204. Published 21 April 2015. (Accessed 1 January 2025). Copyright © P.A. Wackym, MD, used with permission.
19. Wackym, P.A. (2015). Tuning fork testing before and after repair of two types of otic capsule dehiscence. https://www.youtube.com/watch?v=NIauJPbvSpA. doi: 10.13140/RG.2.1.4365.7048. Published 13 December 2015. (Accessed 1 January 2025). Copyright © P.A. Wackym, MD, used with permission.
20. Wackym, P.A., Wood, S.J., Siker, D.A., Carter, D.M. (2015). Otic capsule dehiscence syndrome: Superior canal dehiscence syndrome with no radiographically visible dehiscence. Ear Nose Throat J 94(7):E8-24. doi: 10.1177/014556131509400802
21. Wackym, P.A., Balaban, C.D., Mackay, H.T., et al. (2016). Longitudinal cognitive and neurobehavioral functional outcomes after repairing otic capsule dehiscence. Otol Neurotol 37(1):70-82. doi: 10.1097/MAO.0000000000000928
22. Wackym, P.A., Mackay-Promitas, H.T., Demirel, S., et al. (2017). Comorbidities confounding the outcomes of surgery for third window syndrome: Outlier analysis. Laryngoscope Invest Otolaryngol 2(5):225-253. doi: 10.1002/lio2.89
23. Minor, L.B., Solomon, D., Zinreich, J.S., Zee, D.S. (1998). Sound- and/or pressure-induced vertigo due to bone dehiscence of the superior semicircular canal. Arch Otolaryngol Head Neck Surg. 124(3): 249-58. doi: 10.1001/archotol.124.3.249
24. Minor, L.B. (2005). Clinical manifestations of superior semicircular canal dehiscence. Laryngoscope. 115:b1717–1727. doi: 10.1097/01.mlg.0000178324.55729.b7.
25. Wackym, P.A., Agrawal, Y., Ikezono, T., Balaban, C.D. (2021). Editorial: Third Window Syndrome. Front Neurol. 12: 704095. doi: 10.3389/fneur.2021.704095.
26. Ward, B.K., Carey, J.P., Minor, L.B. (2017). Superior canal dehiscence syndrome: lessons from the first 20 years. Front Neurol. 8: 177. doi: 10.3389/fneur.2017.00177.
27. Wackym, P.A., & Balaban, C.D. (1998). Molecules, motion, and man. Otolaryngol Head Neck Surg 118:S15-S23.
28. Balaban, C.D., & Thayer, J.F. (2001). Neurological bases for balance-anxiety links. J Anxiety Disord 15(1-2):53-79. doi: 10.1016/s0887-6185(00)00042-6
29. Balaban, C.D., McGee, D.M., Zhou, J., Scudder, C.A. (2002). Responses of primate caudal parabrachial nucleus and Kölliker-fuse nucleus neurons to whole body rotation. J Neurophysiol 88:3175–93. doi: 10.1152/jn.00499.2002
30. Balaban, C.D. (2004). Projections from the parabrachial nucleus to the vestibular nuclei: potential substrates for autonomic and limbic influences on vestibular responses. Brain Res 996(1):126-37. doi: 10.1016/j.brainres.2003.10.026
31. Baek, J.H., Zheng, Y., Darlington, C.L., Smith, P.F. (2010). Evidence that spatial memory deficits following bilateral vestibular deafferentation in rats are probably permanent. Neurobiol Learn Mem 94(3):402-13. doi: 10.1016/j.nlm.2010.08.007
32. Smith, P.F., Darlington, C.L., Zheng, Y. (2010). Move it or lose it--is stimulation of the vestibular system necessary for normal spatial memory? Hippocampus 20(1):36-43. doi: 10.1002/hipo.20588
33. Deroualle, D., & Lopez, C. (2014). Toward a vestibular contribution to social cognition. Front Integr Neurosci 8:16. doi: 10.3389/fnint.2014.00016
34. Smith, P.F., & Darlington, C.L. (2013). Personality changes in patients with vestibular dysfunction. Front Hum Neurosci 7:678. doi: 10.3389/fnhum.2013.00678
35. Darlington, C.L., Goddard, M., Zheng, Y., Smith, P.F. (2009). Anxiety-related behavior and biogenic amine pathways in the rat following bilateral vestibular lesions. Ann N Y Acad Sci 1164:134-9. doi: 10.1111/j.1749-6632.2008.03725.x
36. Crane, B.T., Lin, F.R., Minor, L.B., Carey, J.P. (2010). Improvement in autophony symptoms after superior canal dehiscence repair. Otol Neurotol 31(1):140-6.
37. Bhutta, .MF. (2015). Eye movement autophony in superior semicircular canal dehiscence syndrome may be caused by trans-dural transmission of extraocular muscle contraction. Int J Audiol 54(1):61-2.
38. Messina, R., Gollion, C., Christensen, R.H., Amin, F.M. (2022). Functional MRI in migraine. Curr Opin Neurol. 35(3): 328-335. doi: 10.1097/WCO.0000000000001060.
39. Karsan, N., & Goadsby, P.J. (2021). Migraine is more than just headache: is the link to chronic fatigue and mood disorders simply due to shared biological systems? Front Hum Neurosci. 15: 646692. doi: 10.3389/fnhum.2021.646692.
40. Radat, F. (2021). What is the link between migraine and psychiatric disorders? From epidemiology to therapeutics. Rev Neurol (Paris). 177(7): 821-826. doi: 10.1016/j.neurol.2021.07.007.
41. Sharif, S., Saleem, A., Koumadoraki, E., Jarvis, S., Madouros, N., Khan, S. (2021). Headache - a window to dementia: an unexpected twist. Cureus. 13(2): e13398. doi: 10.7759/cureus.13398.
42. Headache Classification Committee of the International Headache Society (IHS). (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 38(1): 1-211. doi: 10.1177/0333102417738202
43. Su, M., Yu, S. (2018). Chronic migraine: a process of dysmodulation and sensitization. Mol Pain. 14: 1744806918767697. doi: 10.1177/1744806918767697.
44. Lipton, R.B., Fanning, K.M., Serrano, D., Reed, M.L., Cady, R., Buse, D.C. (2015). Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology. 84(7): 688-95. doi: 10.1212/WNL.0000000000001256.
45. Scher, A.I., Buse, D.C., Fanning, K.M., et al. (2017). Comorbid pain and migraine chronicity: the Chronic Migraine Epidemiology and Outcomes Study. Neurology. 89(5): 461-468. doi: 10.1212/WNL.0000000000004177.
46. Manack, A., Buse, D.C., Serrano, D., Turkel, C.C., Lipton, R.B. (2011). Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology. 76(8): 711-8. doi: 10.1212/WNL.0b013e31820d8af2.
47. Adams, A.M., Serrano, D., Buse, D.C., et al. (2015). The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results. Cephalalgia. 35(7): 563-78. doi: 10.1177/0333102414552532.
48. Lipton, R.B., Manack Adams, A., Buse, D.C., Fanning, K.M., Reed, M.L. (2016). A comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability. Headache. 56(8): 1280-9. doi: 10.1111/head.12878.
49. Buse, D.C., Manack, A., Serrano, D., Turkel, C., Lipton, R.B. (2010). Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 81(4): 428-32. doi: 10.1136/jnnp.2009.192492.
50. Aurora, S.K. (2009). Spectrum of illness: understanding biological patterns and relationships in chronic migraine. Neurology. 72(5 Suppl): S8-13. doi: 10.1212/WNL.0b013e31819749fd.
51. Cho, S.J., Chu, M.K. (2015). Risk factors of chronic daily headache or chronic migraine. Curr Pain Headache Rep. 19(1): 465. doi: 10.1007/s11916-014-0465-9.
52. Aurora, S.K., Barrodale, P.M., Tipton, R.L., Khodavirdi, A. (2007). Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies. Headache. 47(7): 996-1003; discussion 1004-7. doi: 10.1111/j.1526-4610.2007.00853.x
53. Lai, T.H., Chou, K.H., Fuh, J.L., et al. (2016). Gray matter changes related to medication overuse in patients with chronic migraine. Cephalalgia. 36(14): 1324-1333. doi: 10.1177/0333102416630593.
54. Mathew, N.T. (2011). Pathophysiology of chronic migraine and mode of action of preventive medications. Headache. 51 Suppl 2: 84-92. doi: 10.1111/j.1526-4610.2011.01955.x.
55. Schwedt, T.J., Larson-Prior, L., Coalson, R.S., et al. (2014). Allodynia and descending pain modulation in migraine: a resting state functional connectivity analysis. Pain Med. 15(1): 154-65. doi: 10.1111/pme.12267.
56. Cernuda-Morollón, E., Larrosa, D., Ramón, C., Vega, J., Martínez-Camblor, P., Pascual, J. (2013). Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology. 81(14): 1191-6. doi: 10.1212/WNL.0b013e3182a6cb72.
57. Rossi, C., Pini, L.A., Cupini, M.L., Calabresi, P., Sarchielli, P. (2008). Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. Eur J Clin Pharmacol. 64(1): 1-8. doi: 10.1007/s00228-007-0391-4.
58. Han, X., Dong, Z., Hou, L., et al. (2015). Interictal plasma pituitary adenylate cyclase-activating polypeptide levels are decreased in migraineurs but remain unchanged in patients with tension-type headache. Clin Chim Acta. 450: 151-4. doi: 10.1016/j.cca.2015.08.017.
59. Balaban, C.D., Black, R.D., Silberstein, S.D. (2019). Vestibular neuroscience for the headache specialist. Headache. 59: 1109-1127. doi: 10.1111/head.13550.
60. Wackym, P.A., Balaban, C.D., Van Osch, O.J., et al. (2023). New model of superior semicircular canal dehiscence with reversible diagnostic findings characteristic of patients with the disorder. Front Neurol. 13: 1035478. doi:10.3389/fneur.2022.1035478.
61. Mowery, T.M., Wackym, P.A., Nacipucha, J., et al. (2023). Superior semicircular canal dehiscence and subsequent closure induces reversible impaired decision-making. Front Neurol. 14: 1259030. doi: 10.3389/fneur.2023.1259030.
62. Hong, S.S., Wackym, P.A., Murphy, D.J., et al. (2024). Model of superior semicircular canal dehiscence: asymmetrical vestibular dysfunction induces reversible balance impairment. Front Neurol. 15: 1476004. doi: 10.3389/fneur.2024.1476004. PMID: 39534266; PMCID: PMC11555559. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1476004.
63. Chou, T.M., & Chen, S.P. (2018). Animal Models of Chronic Migraine. Curr Pain Headache Rep. 22(6): 44. doi: 10.1007/s11916-018-0693-5.
64. Vuralli, D., Wattiez, A.S., Russo, A.F., Bolay, H. (2019). Behavioral and cognitive animal models in headache research. J Headache Pain. 20(1): 11. doi: 10.1186/s10194-019-0963-6. PMID: 30704400; PMCID: PMC6734244.
65. Goadsby, P.J., Holland, P.R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., Akerman, S. (2017). Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 97(2): 553-622. doi: 10.1152/physrev.00034.2015.
66. Bigal, M.E., Ashina, S., Burstein, R., et al. (2008). Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology. 70(17): 1525-33. doi: 10.1212/01.wnl.0000310645.31020.b1.
67. Ray, B.S., & Wolff, H.G. (1940). Experimental studies on headache: Pain-sensitive structures of the head and their significance in headache. Arch Surg. 1940, 41:813-856.
68. McAuliffe, G.W., Goodell, H., Wolff, H.G. (1942). Experimental studies on headache: Pain from the nasal and paranasal structures. In: Pain: proceedings of the Association for Research in Nervous and Mental Disease, December 18 and 19, 1942. New York, Williams and Wilkins, Chapter 13, pp. 185-208.
69. Seo, J.G., Park, S.P. (2019). Clinical significance of sensory hypersensitivities in migraine patients: does allodynia have a priority on it? Neurol Sci. 40(2): 393-398. Doi: 10.1007/s10072-018-3661-2.
70. Cammarota, F., De Icco, R., Vaghi, G., et al. (2024). High-frequency episodic migraine: Time for its recognition as a migraine subtype? Cephalalgia. 2024 44(10): 3331024241291578. doi: 10.1177/03331024241291578.
71. Houts, C.R., Wirth, R.J., McGinley, J.S., et al. (2020). Content validity of HIT-6 as a measure of headache impact in people with migraine: a narrative review. Headache. 60(1): 28-39. doi: 10.1111/head.13701.
72. Haywood, K.L., Achana, F., Nichols, V., et al. (2021). Measuring health-related quality of life in chronic headache: a comparative evaluation of the Chronic Headache Quality of Life Questionnaire and Headache Impact Test (HIT-6). Cephalalgia. 41(10): 1100-1123. doi: 10.1177/03331024211006045.
73. Jacobson, G.P., & Newman, C.W. (1990). The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg. 116: 424-7.
74. Furman, J.M., Marcus, D.A., Balaban, C.D. (2013). Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol. 12: 706-15. doi: 10.1016/S1474-4422(13)70107-8.
75. Kesserwani, H. (2021). Migraine triggers: an overview of the pharmacology, biochemistry, atmospherics, and their effects on neural networks. Cureus. 13(4): e14243. doi: 10.7759/cureus.14243.
76. Ho, T.W., Edvinsson, L., Goadsby, P.J. (2010). CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol. 6: 573–82. doi: 10.1038/nrneurol.2010.127 .
77. Xu, D., Chen, D., Zhu, L.N., et al. (2019). Safety and tolerability of calcitonin-gene-related peptide binding monoclonal antibodies for the prevention of episodic migraine - a meta-analysis of randomized controlled trials. Cephalalgia. 39(9): 1164-79. doi10.1177/0333102419829007.
78. Wackym, P.A. (1993). Ultrastructural organization of calcitonin gene-related peptide immunoreactive efferent axons and terminals in the rat vestibular periphery. Am J Otol. 14: 41-50.
79. Raoof, N., Hoffmann, J. (2021). Diagnosis and treatment of idiopathic intracranial hypertension. Cephalalgia. 41(4): 472-478. doi: 10.1177/0333102421997093.
80. Berkiten, G., Gürbüz, D., Akan, O., et al. (2022). Dehiscence or thinning of bone overlying the superior semicircular canal in idiopathic intracranial hypertension. Eur Arch Otorhinolaryngol. 279(6): 2899-2904. doi: 10.1007/s00405-021-07020-z.
81. Kuo, P., Bagwell, K.A., Mongelluzzo, G., et al. (2018). Semicircular canal dehiscence among idiopathic intracranial hypertension patients. Laryngoscope. 128(5): 1196-1199. doi: 10.1002/lary.26795.
82. Kutz, J.W. Jr., & Tolisano, A.M. (2019). Diagnosis and management of spontaneous cerebrospinal fluid fistula and encephaloceles. Curr Opin Otolaryngol Head Neck Surg. 27(5): 369-375. doi: 10.1097/MOO.0000000000000568.